JANE STREET GROUP, LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L901. A total of 4 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$117,600
-70.0%
28,000
-57.1%
0.00%–
Q4 2022$391,852
-50.9%
65,200
-52.4%
0.00%–
Q3 2022$798,000
-43.3%
137,100
-41.9%
0.00%
-100.0%
Q2 2022$1,408,000–235,800–0.00%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 131,200$328,0000.00%
SIMPLEX TRADING, LLC 29,600$74,0000.00%
View complete list of CTI BIOPHARMA CORP shareholders